emduo n kit - Lamivudine (150mg) + Stavudine (30mg) medicine

Triomune 150mg/30mg Tablet: Complete Medicine Guide for HIV Treatment

No reviews yet
🏭 Emcure Pharmaceuticals Ltd 📦 Varies by brand 💊 Allopathy 📅 Updated: Oct 22, 2026
⚠️ Hepatotoxicity Risk 🤰 Pregnancy Category Lamivudine and stavudine are not classified under the old letter-based pregnancy categories in current practice. Stavudine is generally avoided in pregnancy when safer alternatives are available because of concerns about mitochondrial toxicity and lactic acidosis. Lamivudine has a favourable safety profile in pregnancy and is commonly used in prevention of mother-to-child transmission. Any decision to continue or change this medicine during pregnancy must be made by an HIV specialist in consultation with obstetric care. 📋 Prescription Required 💊 Generic Available
Medically Reviewed
12 min read
Evidence: Well-established for HIV treatment as part of combination antiretroviral therapy, but current guidelines recommend safer alternatives because of toxicity.
Reviewed by
SaathiMed Expert Panel | Oct 22, 2026
🩺
Medically Fact-Checked & Clinically Verified by SaathiMed Clinical Review Board
Clinical Reference Standards: CDSCO (Central Drugs Standard Control Organisation), Indian Pharmacopoeia (IP) & WHO | Last Updated: September 2026
Related Clinical Tools & Lab Test Analyzers
View All 26 Tools →

When to Call Your Doctor IMMEDIATELY

  • Rapid or deep breathing, extreme tiredness, or muscle pain that may indicate lactic acidosis
  • Yellowing of the skin or eyes, dark urine, or severe right upper abdominal pain suggesting liver injury
  • Severe upper abdominal pain radiating to the back, often with nausea and vomiting, suggesting pancreatitis
  • New or worsening tingling, numbness, burning, or weakness in the hands or feet
  • Swelling of the face, lips, tongue, or throat, or difficulty breathing suggesting a severe allergic reaction
  • Unusual paleness, severe fatigue, shortness of breath, or frequent infections suggesting blood count abnormalities
  • Persistent fever, swollen lymph nodes, or worsening of existing infections after starting treatment

If experiencing severe symptoms, call emergency services immediately.

What is emduo n kit used for?

This medicine is a combination of lamivudine 150 mg and stavudine 30 mg used as part of HIV treatment. It works by blocking the virus from copying itself, helping to control the infection. It must always be taken with other HIV medicines and under specialist supervision. Because stavudine can cause serious side effects such as nerve damage and lactic acidosis, safer alternatives are now preferred in most guidelines.

  • Generic Name: Lamivudine (150mg) + Stavudine (30mg)
  • Manufacturer: Emcure Pharmaceuticals Ltd
  • Form: Allopathy
  • Pregnancy Category: Consult doctor
  • Prescription Required: Yes

🇮🇳 emduo n kit के बारे में (Hindi Summary)

उपयोग: यह दवा लैमिवुडीन 150 मिलीग्राम और स्टावुडीन 30 मिलीग्राम का संयोजन है, जिसका उपयोग एचआईवी संक्रमण के इलाज के लिए किया जाता है। यह वायरस को शरीर में फैलने से रोकने में मदद करती है और रोग प्रतिरोधक क्षमता को बेहतर बनाए रखने में सहायक होती है। इसे अकेले नहीं लिया जाता, बल्कि अन्य एचआईवी दवाओं के साथ मिलाकर लिया जाता है। यह दवा एचआईवी को पूरी तरह खत्म नहीं करती, लेकिन नियमित रूप से लेने पर वायरस को नियंत्रण में रखती है। स्टावुडीन के कारण नसों में झनझनाहट, दर्द, लैक्टिक एसिडोसिस और लिवर से जुड़ी गंभीर समस्याएँ हो सकती हैं, इसलिए अब इसके सुरक्षित विकल्पों को प्राथमिकता दी जाती है। इस दवा को डॉक्टर की सलाह के बिना शुरू या बंद नहीं करना चाहिए।

साइड इफेक्ट्स: इस दवा के सामान्य दुष्प्रभावों में सिरदर्द, जी मिचलाना, उल्टी, दस्त, पेट में असहजता, थकान, चक्कर आना और हल्के दाने शामिल हैं। स्टावुडीन के कारण हाथ-पैरों में झनझनाहट, सुन्नपन, जलन या दर्द हो सकता है, जिसे तुरंत डॉक्टर को बताना चाहिए। कुछ रोगियों में शरीर की चर्बी का वितरण बदल सकता है, जैसे चेहरे और हाथ-पैरों की चर्बी कम होना और पेट या गर्दन के पीछे चर्बी बढ़ना। दुर्लभ मामलों में लैक्टिक एसिडोसिस, लिवर में गंभीर सूजन, अग्नाशयशोथ और गंभीर एलर्जी हो सकती है। इन लक्षणों को हल्के में न लें और तुरंत चिकित्सा सहायता लें।

सुरक्षा सलाह: इस दवा को डॉक्टर द्वारा बताई गई सही मात्रा और समय पर ही लें। इसे अपने आप बंद या कम-ज्यादा न करें, क्योंकि इससे वायरस में प्रतिरोधक क्षमता विकसित हो सकती है। नियमित रूप से वायरल लोड, सीडी4 काउंट, लिवर और किडनी की जाँच कराते रहें। हाथ-पैरों में झनझनाहट, सुन्नपन या दर्द होने पर तुरंत डॉक्टर को बताएं। तेज सांस लेना, अत्यधिक थकान, मांसपेशियों में दर्द, पेट में तेज दर्द या उल्टी होने पर आपातकालीन चिकित्सा लें। शराब न पिएं क्योंकि इससे लिवर की समस्या बढ़ सकती है। गर्भावस्था या स्तनपान के दौरान डॉक्टर से सलाह लें। किसी भी अन्य डॉक्टर, दंत चिकित्सक या सर्जन को इस दवा के बारे में जरूर बताएं।

💡 Did You Know? India is the largest provider of generic medicines globally, supplying over 50% of global vaccine demand.

💊 emduo n kit Uses & Benefits

[{"condition":"Human immunodeficiency virus type 1 infection","description":"Used as part of combination antiretroviral therapy to suppress viral replication, improve CD4 cell counts, and reduce HIV-related illness and death in adults and adolescents.","evidence":"Well-established"},{"condition":"Prevention of mother-to-child transmission of HIV","description":"Historically used in some antiretroviral regimens to reduce vertical transmission, although safer alternatives are now preferred in most guidelines.","evidence":"Historical use; current guidelines favour alternative agents"},{"condition":"Post-exposure prophylaxis of HIV","description":"May be included in some older or resource-limited post-exposure prophylaxis regimens, but current practice generally uses better-tolerated combinations.","evidence":"Limited; not first-line in current guidelines"}]

Off-label uses: [{"condition":"Hepatitis B virus infection","description":"Lamivudine, one component of this medicine, has activity against hepatitis B virus and has been used in selected patients, but this combination is not a recommended treatment for hepatitis B because of stavudine toxicity.","evidence":"Limited and not recommended for this combination"}]

Primary treatment for: Human immunodeficiency virus type 1 infection

Also treats: Acquired immunodeficiency syndrome, Hepatitis B co-infection, Tuberculosis co-infection, Opportunistic infections associated with advanced HIV

📋 Drug Information

Generic Name(s)Lamivudine (150mg) + Stavudine (30mg)
Brand Nameemduo n kit
ManufacturerEmcure Pharmaceuticals Ltd
Packaging / FormVaries by brand (Allopathy)
Therapeutic ClassANTI INFECTIVES
Action Class
Route of AdministrationOral
StorageStore this medicine at room temperature between 15°C and 30°C in a dry place. Keep it in the original container with the lid tightly closed. Protect it from direct sunlight, heat, and moisture. Do not store it in the bathroom or near the kitchen sink. Keep all medicines out of the reach of children and pets.
Shelf LifeThe shelf life of this medicine is typically 24 months from the date of manufacture when stored under recommended conditions. Always check the expiry date printed on the pack and do not use the medicine after that date. Do not use the tablet if it is broken, discoloured, or shows signs of deterioration.
WHO GuidelineCurrent World Health Organization guidelines for HIV treatment recommend dolutegravir-based regimens as the preferred first-line therapy for adults and adolescents. Stavudine-containing combinations such as this medicine are no longer recommended as first-line treatment because of toxicity, particularly peripheral neuropathy, lipodystrophy, and lactic acidosis. This medicine may still be encountered in older prescriptions or in settings where safer alternatives are not yet available, but it should be replaced with a better-tolerated regimen when possible.
ICMR GuidelineIndian Council of Medical Research and National AIDS Control Organisation guidelines follow the principle of using effective, well-tolerated antiretroviral combinations. Stavudine is no longer preferred in first-line regimens in India because of its toxicity profile. Patients currently taking this medicine should be reviewed by an HIV specialist to consider switching to a safer alternative, in line with national programme recommendations.

👨‍⚕️ Doctor's Practical Tips

Evidence-based practical advice from experienced clinicians

1
Confirm the patient's renal function before prescribing this medicine, because both lamivudine and stavudine require dose adjustment in kidney impairment.
2
Counsel every patient about peripheral neuropathy at the first visit and ask specifically about tingling, numbness, or burning in the hands and feet at each follow-up.
3
Emphasise that this medicine must never be used as monotherapy and must always be part of a fully active combination antiretroviral regimen.
4
Review the patient's other medicines for zidovudine, didanosine, ribavirin, and other neurotoxic or pancreatotoxic agents before continuing this combination.
5
Check liver enzymes, blood counts, and viral load regularly, and consider switching to a safer regimen if toxicity or poor tolerability develops.
6
Advise patients to report muscle pain, rapid breathing, or severe fatigue immediately, as these may be early signs of lactic acidosis.
7
Discuss contraception and pregnancy plans with all patients of childbearing potential, because stavudine is generally avoided in pregnancy when alternatives exist.
8
Reinforce adherence at every visit using pill counts, pharmacy refill records, or self-report, and address barriers such as stigma, cost, and side effects.

🔍 Is This Medicine Right for Your Symptom?

Educational reference. Always consult a doctor for diagnosis.

✅
Confirmed HIV infection
This medicine is prescribed as part of combination antiretroviral therapy for HIV.
Likely Use
❌
Tingling or numbness in hands and feet
This may be a side effect of stavudine and should be reported to the doctor immediately.
Not Primary
❌
Fever
This medicine is not a fever reducer; fever may indicate infection or another condition.
Not Primary
❌
Chronic joint pain
This medicine is not used for joint pain.
Not Primary
✅
Unexplained weight loss with HIV
Antiretroviral therapy including this medicine can help restore health and weight when HIV is the cause.
Likely Use

🔬 How This Medicine Works (Pharmacology)

Pharmacokinetics

AbsorptionLamivudine is rapidly absorbed after oral administration, and stavudine is also well absorbed from the gastrointestinal tract. Food does not significantly affect the extent of absorption of either component, although it may slightly slow the rate. Specific numerical bioavailability values for this fixed-dose combination are not established from the available information.
DistributionBoth lamivudine and stavudine distribute into total body water and enter cells where they are phosphorylated. Lamivudine crosses the blood-brain barrier to some extent, which is relevant for HIV in the central nervous system. Detailed volume of distribution values for this combination are not established from the available information.
Protein BindingLamivudine has low plasma protein binding, reported to be less than 36 percent. Stavudine also has low plasma protein binding. Specific binding values for this fixed-dose combination are not established from the available information.
MetabolismLamivudine is not extensively metabolised by the liver and is mainly eliminated unchanged in the urine. Stavudine is also primarily eliminated unchanged by renal excretion and does not significantly induce or inhibit the cytochrome P450 enzyme system. Because neither component depends heavily on hepatic metabolism, this combination has a relatively low potential for cytochrome P450-based drug interactions.
Half-LifeThe elimination half-life of lamivudine is approximately 5 to 7 hours in adults with normal renal function. The elimination half-life of stavudine is approximately 1 to 1.6 hours. Half-lives are prolonged in patients with renal impairment, and dose adjustment is required.
ExcretionLamivudine is excreted primarily unchanged in the urine by glomerular filtration and active tubular secretion. Stavudine is also excreted largely unchanged in the urine. Renal impairment reduces clearance of both drugs and increases the risk of toxicity, so renal function should be assessed before and during treatment.
BioavailabilityLamivudine has high oral bioavailability, reported to be approximately 80 to 85 percent in adults. Stavudine also has high oral bioavailability, reported to be approximately 80 to 99 percent. Specific bioavailability data for this fixed-dose combination product are not established from the available information.
Onset of ActionAntiretroviral activity begins soon after the first doses, but measurable reductions in plasma HIV RNA are usually seen within one to two weeks of starting effective combination therapy. Full clinical benefit, including CD4 recovery and reduced risk of opportunistic infections, develops over months of consistent treatment.
Peak Plasma TimeLamivudine reaches peak plasma concentrations approximately 0.5 to 2 hours after oral administration. Stavudine reaches peak plasma concentrations approximately 0.5 to 1.5 hours after oral administration.
Duration of ActionThe antiviral effect of this medicine depends on maintaining adequate intracellular concentrations of the active triphosphates. Lamivudine triphosphate has a long intracellular half-life, allowing once-daily or twice-daily dosing depending on the regimen. Stavudine triphosphate also persists intracellularly, but the overall duration of action is determined by the dosing schedule prescribed by the clinician.

How It Works

This medicine combines two nucleoside reverse transcriptase inhibitors that act on the same viral enzyme through different chemical forms. Lamivudine is a cytidine analogue, and stavudine is a thymidine analogue. After entering the body, each drug is converted inside cells into its active triphosphate form. These active triphosphates compete with the natural building blocks of viral DNA and are incorporated into the growing viral DNA chain. Because they lack the chemical group needed to attach the next nucleotide, they terminate further chain elongation. This blocks reverse transcriptase from converting viral RNA into DNA, which is an essential step in the HIV replication cycle. The combination of two agents with different resistance profiles helps to suppress viral replication more effectively than either drug alone and reduces the chance that resistant virus will emerge.

Mechanism Steps

1
Entry into the cell: Lamivudine and stavudine are taken up from the bloodstream into human cells, including CD4 T lymphocytes and other HIV target cells.
2
Intracellular phosphorylation: Inside the cell, lamivudine and stavudine are converted by cellular kinases into their active triphosphate forms, which are the molecules that actually inhibit the virus.
3
Competition with natural nucleotides: The active triphosphates compete with the natural deoxynucleotides that reverse transcriptase normally uses to build viral DNA.
4
Incorporation into viral DNA: Reverse transcriptase mistakenly inserts the drug triphosphate into the growing viral DNA chain in place of the natural nucleotide.
5
Chain termination: Because the incorporated drug lacks the 3-hydroxyl group required for the next nucleotide linkage, the viral DNA chain cannot be extended further.
6
Suppression of viral replication: Without complete viral DNA, HIV cannot integrate into the host genome or produce new viral particles, so viral replication is suppressed.

💡 How to Take emduo n kit

Strength: Immediate-release tablet containing lamivudine 150 mg and stavudine 30 mg.

1Wash your hands and take the tablet out of the original container.
2Swallow the tablet whole with a full glass of water; do not crush or chew it unless your doctor advises otherwise.
3Take it at the same times each day, ideally every 12 hours, to maintain steady drug levels.
4You may take it with or without food, but a light meal may reduce nausea.
5If you also take antacids, separate them by about two hours.
6Do not take a double dose if you miss one; follow the missed dose instructions.
7Keep a daily reminder or pill box to help maintain adherence.
8Store the container properly and keep it out of reach of children.

Dosage Information

Adult DosageThe usual adult dose of this fixed-dose combination is one tablet taken orally every 12 hours, which provides lamivudine 150 mg and stavudine 30 mg per dose. Some clinicians may prescribe one tablet every 24 hours in specific situations, but this must be decided by the HIV specialist. The dose must be individualised by a qualified clinician based on indication, age, weight, renal and hepatic function, and the rest of the antiretroviral regimen. Patients weighing less than 60 kg may require a different stavudine strength. Never adjust the dose without medical advice.
Pediatric DosagePediatric dosing of this fixed-dose combination is not established from available information. Stavudine and lamivudine are used in children in weight-based doses, but this specific tablet strength is generally intended for adults and older adolescents. Consult a pediatrician or pediatric HIV specialist for appropriate dosing in children.
Elderly DosageElderly patients may have reduced renal function, which can increase blood levels of lamivudine and stavudine and raise the risk of side effects. Renal function should be assessed before starting treatment, and the dose should be adjusted by the clinician if creatinine clearance is reduced. Elderly patients should be monitored more closely for peripheral neuropathy, fatigue, and metabolic changes.
Renal ImpairmentDose adjustment is required in patients with renal impairment because both lamivudine and stavudine are eliminated mainly by the kidneys. The exact dose depends on creatinine clearance and must be determined by the treating clinician. In severe renal impairment, alternative antiretroviral medicines may be preferred. Regular monitoring of renal function is essential during treatment.
Hepatic ImpairmentNo specific dose adjustment is usually required for mild to moderate hepatic impairment, but this medicine should be used with caution in patients with liver disease. It is contraindicated in severe hepatic impairment or decompensated liver disease. Liver function tests should be monitored regularly, and patients with hepatitis B or C co-infection need careful follow-up.
Maximum Daily DoseThe maximum recommended adult daily dose is one tablet every 12 hours, providing lamivudine 300 mg and stavudine 60 mg per day. Higher doses should not be taken unless specifically prescribed by the HIV specialist. Dose must be individualised by a qualified clinician based on indication, age, weight, renal and hepatic function.

Dosage Timeline

🌅 Morning ❌ ☀️ Afternoon ❌ 🌆 Evening ❌ 🌙 Night ❌

🍽️ Food Timing Guide

Light meal or snack
May take with food
Reduces nausea and stomach discomfort.
Alcohol
Avoid
Increases risk of liver problems, fatigue, and neuropathy.
High-fat meals
No specific restriction
May slightly slow absorption but does not require dose adjustment.
Antacids
Separate by about 2 hours
May affect absorption of some medicines; separation is a precaution.

⏰ What to Do If You Miss a Dose

📌 Less than 6 hours have passed since the missed 12-hourly dose
→ Take the missed dose as soon as you remember.
💡 Continue with your regular 12-hourly schedule.
📌 More than 6 hours have passed since the missed 12-hourly dose
→ Skip the missed dose and take the next dose at the usual time.
💡 Do not take two doses together to catch up.
📌 You are unsure whether to take the missed dose
→ Contact your HIV specialist or pharmacist for advice.
💡 Never stop the medicine on your own.

⚠️ Side Effects of emduo n kit

✅ Common Side Effects

Headache (Common)
Rest, stay hydrated, and use simple pain relief if advised by your doctor. Seek medical advice if headaches are severe or persistent.
Nausea (Common)
Take the tablet with a light meal or snack. Inform your doctor if nausea interferes with eating or drinking.
Diarrhoea (Common)
Maintain fluid intake. Contact your doctor if diarrhoea is severe, bloody, or associated with dehydration.
Fatigue (Common)
Ensure adequate rest and nutrition. Report persistent or worsening tiredness to your doctor.
Peripheral neuropathy (Common with stavudine)
Report tingling, numbness, burning, or pain in the hands or feet immediately. Early dose adjustment or change of regimen may prevent permanent nerve damage.
Rash (Uncommon)
Monitor the rash. Seek urgent care if it is accompanied by fever, blisters, mouth sores, or swelling of the face or lips.

🚨 Serious Side Effects

Lactic acidosis (Rare)
Seek emergency medical care for rapid breathing, extreme fatigue, muscle pain, nausea, vomiting, or abdominal pain.
Severe hepatomegaly with steatosis (Rare)
Go to the nearest emergency department if you develop yellowing of the eyes or skin, dark urine, or severe abdominal pain.
Pancreatitis (Rare)
Seek immediate medical attention for severe upper abdominal pain that may radiate to the back, often with nausea and vomiting.
Severe peripheral neuropathy (Uncommon to rare)
Contact your HIV specialist promptly if you develop persistent or worsening numbness, burning, or weakness in the limbs.
Severe hypersensitivity reaction (Rare)
Stop the medicine and seek emergency care for swelling of the face, lips, tongue, or throat, difficulty breathing, or widespread blistering rash.
Severe anaemia or neutropenia (Uncommon)
Report unusual tiredness, pallor, shortness of breath, or frequent infections to your doctor for blood count evaluation.

⚠️ Rare Side Effects

Immune reconstitution inflammatory syndrome
Report new or worsening fever, swollen lymph nodes, or worsening of existing infections to your HIV specialist.
Lipoatrophy and metabolic changes
Discuss changes in body fat distribution, blood sugar, or cholesterol with your doctor during routine monitoring.
Myopathy
Report progressive muscle weakness or muscle pain to your doctor for evaluation.

Consult your doctor if you experience any unusual symptoms.

🔬 Drug Interactions

Drug Severity Effect
Zidovudine Major
Didanosine Major
Ribavirin Major
Doxorubicin Moderate
Trimethoprim-sulfamethoxazole Moderate
Amphotericin B Moderate
Isoniazid Moderate
Pentamidine Moderate
Valproic acid Moderate
Paracetamol Minor

🚨 Major Interactions

  • Zidovudine
  • Didanosine
  • Ribavirin
  • Doxorubicin

⚡ Moderate Interactions

  • Trimethoprim-sulfamethoxazole
  • Nephrotoxic medicines such as amphotericin B or aminoglycosides
  • Medicines that cause peripheral neuropathy such as isoniazid, vincristine, or phenytoin
  • Medicines that cause pancreatitis such as pentamidine or valproic acid

🍷 Alcohol Interaction

Alcohol should be avoided while taking this medicine. Both HIV infection and antiretroviral medicines can affect the liver, and alcohol increases the risk of liver inflammation, fatty liver, and lactic acidosis. Alcohol can also worsen fatigue, dizziness, and peripheral neuropathy. If you drink alcohol, discuss safe limits with your doctor, but complete avoidance is strongly preferred during treatment.

🔎 Check Your Other Medicines

Educational tool. Always confirm with your doctor or pharmacist.

🛡️ Safety & Warnings

🚫 Contraindications

["Known hypersensitivity or allergy to lamivudine, stavudine, or any component of the tablet","Previous lactic acidosis or severe liver enlargement with fatty liver related to nucleoside analogues","Severe hepatic impairment or decompensated liver disease","Concurrent use with zidovudine because of antagonism","Concurrent use with didanosine unless no alternative is available and close monitoring is possible","Pregnancy or planning pregnancy when safer antiretroviral alternatives are available","Breastfeeding in settings where safe replacement feeding is feasible","Severe renal impairment without appropriate dose adjustment"]

⚠️ Warnings & Precautions

["This medicine must never be used as monotherapy for HIV; it must always be part of a combination antiretroviral regimen.","Peripheral neuropathy is a common and potentially irreversible side effect of stavudine; report early symptoms immediately.","Lactic acidosis and severe hepatomegaly with steatosis are rare but life-threatening; seek emergency care for suggestive symptoms.","Pancreatitis has been reported with stavudine; avoid other medicines that increase pancreatitis risk where possible.","Renal impairment requires dose adjustment; renal function should be checked before and during treatment.","Patients with hepatitis B co-infection may experience flare of hepatitis when lamivudine is stopped; monitor liver enzymes closely.","Lipodystrophy and metabolic changes may occur with prolonged stavudine use; regular assessment is advised.","Adherence is critical; missed doses can lead to drug resistance and treatment failure.","Do not share this medicine with anyone else, even if they have similar symptoms.","Inform all healthcare providers about this medicine before any surgery, dental procedure, or new prescription."]

🤱 Lactation Safety

Both lamivudine and stavudine are excreted in human breast milk. In many settings, mothers living with HIV are advised to use formula feeding when safe and feasible to prevent transmission of HIV through breast milk. In resource-limited settings where formula feeding is not safe, exclusive breastfeeding with maternal antiretroviral therapy may be recommended by national guidelines. The choice must be individualised with the treating doctor and paediatrician.

💊 Overdose Management

There is no specific antidote for overdose with this medicine. If an overdose is suspected, contact emergency medical services or a poison control centre immediately. Treatment is supportive and may include monitoring of vital signs, blood counts, liver function, renal function, and blood gases. Because lamivudine and stavudine are eliminated by the kidneys, haemodialysis may be considered in severe cases, although its effectiveness for stavudine is limited. Do not attempt to induce vomiting unless instructed by a healthcare professional.

⏰ Missed Dose

If you miss a dose of this medicine, take it as soon as you remember if less than half of the usual dosing interval has passed. If more than half of the dosing interval has passed, skip the missed dose and continue with your regular schedule. Never take two doses at the same time to make up for a missed dose. If you are unsure what to do, contact your HIV specialist or pharmacist for guidance. Consistent adherence is essential to keep the virus suppressed and prevent resistance.

Additional Safety Advice

General Safety

Take this medicine exactly as prescribed by your HIV specialist, at the same time each day, with or without food according to your doctor's instruction. Never stop, skip, or change the dose on your own, because irregular use allows the virus to become resistant and limits future treatment options. Keep all scheduled laboratory appointments, including CD4 count, viral load, liver function tests, kidney function tests, blood counts, and blood sugar or lipid checks. Report tingling, numbness, or burning in the hands or feet immediately, as early recognition of peripheral neuropathy can prevent permanent damage. Watch for rapid breathing, extreme tiredness, muscle pain, nausea with vomiting, or abdominal pain, which may signal lactic acidosis and require emergency care. Inform every healthcare provider, including dentists and surgeons, that you are taking this medicine. Use condoms consistently to prevent transmission of HIV and other sexually transmitted infections. Do not share needles, razors, or toothbrushes. Avoid alcohol because it increases the risk of liver problems. If you are pregnant, planning pregnancy, or breastfeeding, speak to your doctor before continuing this medicine, as safer alternatives may be available.

👴 Special Considerations for Elderly

💡 For Patients Above 65

Elderly patients are more likely to have reduced kidney function, which can increase blood levels of lamivudine and stavudine and raise the risk of side effects. Renal function should be checked before starting treatment and monitored regularly. Elderly patients should also be monitored closely for peripheral neuropathy, fatigue, falls, and metabolic changes. The dose may need adjustment based on creatinine clearance.

🤰 Pregnancy Planning (TTC)

If you are planning pregnancy, speak to your HIV specialist before conception. Stavudine is generally avoided in pregnancy when safer alternatives are available because of the risk of mitochondrial toxicity and lactic acidosis. Your doctor may switch you to a regimen containing lamivudine with tenofovir or abacavir and dolutegravir, which are considered safer in pregnancy. Effective HIV treatment before and during pregnancy greatly reduces the risk of transmitting HIV to the baby.

🏥 Post-Surgery Considerations

Inform your surgeon and anaesthetist that you are taking this medicine before any surgery. Continue taking it as prescribed unless your doctor advises otherwise. After surgery, monitor for signs of infection, delayed wound healing, or unusual fatigue. Some anaesthetic agents and pain medicines may interact with your antiretroviral regimen, so a full medication review is important. Your HIV specialist should be involved in your post-operative care.

🦷 Dental Procedures

Tell your dentist that you are taking this medicine before any dental procedure. HIV medicines can cause dry mouth, and stavudine-related peripheral neuropathy may affect tolerance of dental procedures. There is no need to stop this medicine for dental work, but your dentist should be aware of your HIV status and medicines to provide safe care. Maintain good oral hygiene and attend regular dental check-ups.

💚 Lifestyle Tips for Better Results

🏃
Take your medicine at the same times every day and use reminders or a pill organiser to maintain adherence.
🥗
Eat a balanced diet rich in fruits, vegetables, whole grains, and lean protein to support immune function.
😴
Stay physically active with moderate exercise such as walking, swimming, or yoga, as tolerated.
💧
Get adequate sleep and manage stress through relaxation techniques or counselling.
🧘
Avoid alcohol and recreational drugs, which can worsen liver health and interfere with treatment.
🌞
Practice safe sex and use condoms consistently to prevent transmission of HIV and other infections.
🚭
Attend all scheduled clinic visits and laboratory tests without fail.
🥑
Seek emotional support from family, friends, or HIV support groups to cope with the diagnosis and treatment.

🏋️ Exercise Considerations

Moderate exercise is generally safe and beneficial while taking this medicine. However, if you develop peripheral neuropathy, avoid high-impact activities that could injure numb feet, and choose low-impact exercises such as swimming or cycling. If you experience severe fatigue, muscle pain, or shortness of breath, stop exercising and seek medical advice, as these may be signs of lactic acidosis or anaemia.

🥗 Diet Recommendations

Include protein-rich foods such as lentils, beans, eggs, fish, and lean meat to support immune recovery.
Eat plenty of fruits and vegetables for vitamins and antioxidants.
Choose whole grains such as brown rice, oats, and whole wheat for sustained energy.
Limit sugary drinks and processed foods to help control blood sugar and cholesterol.
Stay well hydrated by drinking plenty of water throughout the day.
Avoid alcohol completely, as it increases the risk of liver problems and neuropathy.

💼 Impact on Daily Work & Life

Most people can continue their usual work and daily activities while taking this medicine. However, fatigue, dizziness, or peripheral neuropathy may affect driving or operating heavy machinery. If you feel dizzy or unusually tired, avoid driving until you feel better. Peripheral neuropathy can affect balance and grip, so take precautions with tasks that require fine motor skills. Discuss any work-related concerns with your doctor, and request workplace accommodations if needed.

🛑 When to Stop This Medicine

Do not stop this medicine on your own. It should only be stopped or changed by your HIV specialist. If you develop serious side effects such as lactic acidosis, severe liver problems, pancreatitis, or worsening peripheral neuropathy, contact your doctor immediately; they may decide to stop the medicine and switch you to a safer regimen. If you need to stop for any reason, your doctor will monitor your viral load and liver function closely, especially if you have hepatitis B co-infection.

📅 Long-Term Use Effects

Long-term use of this medicine is associated with peripheral neuropathy, lipodystrophy, metabolic changes such as increased blood sugar and cholesterol, and rare but serious mitochondrial toxicity including lactic acidosis. Regular monitoring of viral load, CD4 count, liver function, renal function, blood counts, and metabolic parameters is essential. Because of these long-term risks, current guidelines recommend switching to safer antiretroviral combinations whenever possible. Patients should remain under the care of an HIV specialist for lifelong follow-up.

🌿 Non-Medicine Approaches

These can complement medicine but do not replace prescribed treatment.

Switch to a dolutegravir-based regimen

Current guidelines recommend dolutegravir combined with two nucleoside reverse transcriptase inhibitors such as tenofovir and lamivudine as a safer and more effective first-line HIV treatment.

Evidence: Well-established
Tenofovir and lamivudine backbone

This combination has a better safety profile than stavudine-containing regimens and is widely used in modern HIV treatment.

Evidence: Well-established
Abacavir and lamivudine backbone

An alternative nucleoside backbone for patients who are HLA-B*5701 negative and have no contraindications.

Evidence: Well-established
Adherence support programmes

Counselling, peer support, and reminder tools help patients maintain viral suppression and prevent resistance.

Evidence: Well-established

💉 Vaccination Considerations

💉 If You're Getting Vaccinated

Patients living with HIV should receive appropriate vaccinations, including influenza, pneumococcal, hepatitis B, and COVID-19 vaccines, according to national guidelines. Live vaccines may be contraindicated in patients with severely weakened immune systems, so always consult your HIV specialist before any vaccination. Vaccination status should be reviewed regularly as part of comprehensive HIV care.

📦 Storage Guide

✅ DO

Store at room temperature between 15°C and 30°C

❌ DON'T

Do not refrigerate unless specifically instructed

✅ DO

Keep in the original labelled container

❌ DON'T

Do not transfer to unmarked containers

✅ DO

Keep away from direct sunlight and moisture

❌ DON'T

Do not store in the bathroom or near the kitchen sink

✅ DO

Keep out of reach of children and pets

❌ DON'T

Do not use after the expiry date

✈️ Traveling with This Medicine

Carry this medicine in its original labelled container with a copy of your prescription and a letter from your HIV specialist stating your diagnosis and treatment. Carry enough supply for the entire trip plus extra in case of delays. Keep it in your hand luggage rather than checked baggage to avoid loss or temperature extremes. Store it at room temperature and protect it from direct sunlight and moisture. If you are crossing time zones, ask your doctor how to adjust dosing times; usually you can maintain a 12-hour interval by shifting gradually. Declare your medicines at customs if required and check local regulations about carrying antiretroviral medicines. Never share your medicine with anyone else.

💰 Cost Analysis & Savings

👥 Real Patient Stories

Educational, anonymized scenarios. Individual results may vary.

👤 A 38-year-old man living with HIV who had been on this medicine for several months
He noticed tingling and burning in both feet but initially ignored it, thinking it would go away. When the symptoms worsened and began affecting his sleep, he informed his HIV specialist. The doctor recognised stavudine-related peripheral neuropathy and switched him to a safer antiretroviral regimen. His symptoms gradually improved over the following weeks.
💡 Lesson: Early reporting of tingling or numbness in the hands or feet is essential because timely change of treatment can prevent permanent nerve damage.
👤 A 45-year-old woman who occasionally missed doses because of a busy work schedule
She felt well and sometimes forgot her evening dose. At a routine visit, her viral load had increased, and the doctor explained that missed doses allow the virus to develop resistance. With counselling, a pill organiser, and mobile reminders, she improved her adherence, and her viral load became undetectable again.
💡 Lesson: Taking this medicine exactly as prescribed, every day without fail, is critical to keep HIV suppressed and prevent resistance.
👤 A 52-year-old man who developed nausea and fatigue after starting this medicine
He was worried that the medicine was harming him and considered stopping it. His doctor explained that mild nausea and fatigue are common early side effects and advised taking the tablet with a light meal. The symptoms settled within a few weeks, and he continued treatment successfully.
💡 Lesson: Common early side effects often improve with time and simple measures, but patients should always consult their doctor before stopping any HIV medicine.

💬 Questions Patients Often Ask

Q: How long does it take to work?

A: This medicine starts reducing the virus within one to two weeks, but full suppression of HIV usually takes several weeks to months of consistent combination therapy. Viral load is checked regularly to confirm that the treatment is working.

Q: Can I stop this medicine if I feel better?

A: No. Feeling better does not mean the virus is gone. Stopping this medicine can cause the virus to rebound and become resistant. Always consult your HIV specialist before any change.

Q: What are the most important side effects to watch for?

A: Watch for tingling, numbness, or burning in the hands or feet, which may indicate nerve damage. Also report rapid breathing, extreme tiredness, muscle pain, severe abdominal pain, or yellowing of the eyes or skin immediately.

Q: Can I take this medicine with other HIV medicines?

A: This medicine is always taken with other HIV medicines as part of a combination regimen. However, it should not be combined with zidovudine or didanosine because of antagonism and increased toxicity.

Q: Is this medicine safe in pregnancy?

A: Stavudine is generally avoided in pregnancy when safer alternatives are available. Lamivudine is considered safe. If you are pregnant or planning pregnancy, speak to your HIV specialist about switching to a safer regimen.

Q: How should I store this medicine?

A: Store it at room temperature between 15°C and 30°C in the original container, away from sunlight, heat, and moisture. Keep it out of reach of children.

🤔 Common Patient Concerns

💭 These are the concerns patients most commonly raise

  • Can I take this medicine long-term?
  • Will it affect my kidney function?
  • Can I drive after taking this medicine?
  • Does it interact with my tuberculosis medicine?
  • What if I miss a dose?
  • Can I drink alcohol while taking this?
  • Is this medicine safe during pregnancy?
  • Will this medicine cause nerve damage?
  • Can I switch to a safer HIV medicine?
  • How often should I get blood tests?

🔄 Substitutes for emduo n kit

View All

Alternative brands with exact same active ingredient:

Medical Note: Always consult your doctor before switching medications.

🛑 Myths vs. Facts

  • Myth: This medicine can cure HIV.
    Fact: This medicine controls HIV but does not cure it. It must be taken consistently as part of lifelong combination therapy.
  • Myth: I can stop this medicine once my viral load becomes undetectable.
    Fact: Stopping treatment allows the virus to rebound and can lead to resistance. Treatment is lifelong unless changed by a specialist.
  • Myth: This medicine can be taken alone for HIV.
    Fact: It must always be combined with other antiretroviral medicines to prevent resistance and achieve viral suppression.
  • Myth: Side effects mean the medicine is not working.
    Fact: Side effects can occur even when the medicine is working well. Report them to your doctor rather than stopping the medicine.
  • Myth: HIV medicines are no longer needed if I feel healthy.
    Fact: HIV can damage the immune system silently. Regular treatment keeps the virus suppressed and protects your health.

🔄 Alternative Options

Generic Alternatives

  • Lamivudine 150 mg and stavudine 30 mg fixed-dose combination tablets from other manufacturers
  • Separate lamivudine 150 mg tablets and stavudine 30 mg capsules taken together

Brand Alternatives

  • Triomune 150mg/30mg/200mg tablet

📊 Comparison with Similar Medicines

[{"medicine":"This medicine (lamivudine + stavudine)","class":"Nucleoside reverse transcriptase inhibitor combination","common_use":"HIV treatment as part of combination therapy","key_note":"Effective but limited by stavudine toxicity; no longer first-line"},{"medicine":"Lamivudine + zidovudine","class":"Nucleoside reverse transcriptase inhibitor combination","common_use":"HIV treatment as part of combination therapy","key_note":"Better tolerated than stavudine in many patients but can cause anaemia"},{"medicine":"Tenofovir + lamivudine","class":"Nucleoside/nucleotide reverse transcriptase inhibitor combination","common_use":"Preferred backbone in many current HIV regimens","key_note":"Better safety profile and widely recommended"},{"medicine":"Abacavir + lamivudine","class":"Nucleoside reverse transcriptase inhibitor combination","common_use":"HIV treatment as part of combination therapy","key_note":"Requires HLA-B*5701 testing before use"}]

😊 Was this information helpful?

Browse Medicines A-Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Back to Medicines Directory